ProQR Therapeutics N.V.
ProQR Therapeutics N.V. (PRQR) Stock Overview
Explore ProQR Therapeutics N.V.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
247.3M
P/E Ratio
-7.05
EPS (TTM)
$-0.39
ROE
-0.54%
PRQR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ProQR Therapeutics N.V. (PRQR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.41.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.05 and a market capitalization of 247.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.